Latest News | May 28, 2022

The Week in Review in Prescription Drug Pricing

Welcome to the Week in Review.

1. Voters Are Watching

2. Americans United: Drug Pricing Reform Now

3. More Bad Behavior


One more thing: As the Senate works on a reconciliation bill with drug pricing reforms, states are moving ahead to protect their residents from high prices. Maryland’s prescription drug affordability board — the first of its kind in the nation — began its work to establish upper payment limits this week, and a New Jersey bill to establish a drug affordability board passed a critical committee vote in the state Assembly. Thank you to all state lawmakers fighting for patients!

Have a great weekend, everyone!

WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now, following Jamie McLeod-Skinner’s primary victory in Oregon’s 5th Congressional District:

“Drug price reform figured prominently in Oregon’s 5th Congressional District primary, where Rep. Kurt Schrader tried to reinvent himself as pro-patient and anti-Big Pharma when he in fact led the effort to weaken legislation allowing Medicare negotiation. Voters saw through his lies, and for the first time in 42 years, an incumbent member of Congress lost his job in an Oregon primary. The result sends a clear message to Democrats and Republicans alike: Americans want Congress to pass legislation to lower drug prices, and those who stand in the way or fail to deliver on their promises will be held accountable by voters at the ballot box. More talk won’t do. Fake solutions won’t do. No more excuses. Right now, the Senate can deliver on its promises; the votes are there. The Senate must use its power under reconciliation now to enact the comprehensive reforms to lower drug prices already passed by the House of Representatives.”

###

ICYMI: Roundup Of Overwhelming Momentum To Advance Comprehensive Drug Pricing Reforms By Memorial Day

70 Organizations Continue “Push For Lower Rx Prices” 

Members Of Congress And President Biden Push For Lower Rx Prices

Senate Outreach And Digital Blitz

###

Welcome to the Week in Review.

1. “We Have The Backing Of The American People”

2. This Is Why We’re Fighting


3. Profits Over Patients

Have a great weekend, everyone!

Big Pharma may want us to think the odds are stacked against us, but Rich Strike proved that no odds are too great to overcome.

Welcome to the Week in Review.

1. Time To Reset The System

2. In Focus: A Texas Patient’s Story

3. Let Medicare Negotiate. Now.

Have a great weekend, everyone!

Welcome to the Week in Review.

1. New Patient Ads: “It’s Time To Get It Done”

2. Undeniable Momentum  


3. Tweetorial: Unaffordable Cancer Drugs   


One more thing: P4ADNow submitted comments to the Federal Trade Commission (FTC) this week describing the ways that the opaque business practices of pharmacy benefit managers (PBMs) may contribute to higher prices for patients and calling for a thoroughgoing investigation into PBM business practices. 

Have a great weekend, everyone!

Our #1 overall pick to lower drug prices? Medicare negotiation.

Welcome to the Week in Review.

1. The Push For Lower Rx Prices

2. Voters Demand Medicare Negotiation


3. Read Our Stories

Have a great weekend, everyone!

Which costs more: a first-round NBA playoff game ticket, a Coachella ticket, or a bottle of the blood thinner Xarelto? Click here to find out.

Welcome to the Week in Review.

1. “It’s Simply Wrong”

2. We’re Not Buying Big Pharma’s Lies


3. “Lives On The Line”

4. The Patents Behind Monopoly Prices

5. Another Drug Industry Game

One more thing: On Tuesday, April 26, over 70 organizations will join together to launch the campaign “Push For Lower Rx Prices” to call on the Senate to advance a reconciliation package that includes drug pricing reforms by Memorial Day. Please RSVP to [email protected] to attend the press conference.

Have a great weekend, everyone!